DERMATHEEK
0441.223.009 · rovalta.com · 23/09/2026
DERMATHEEK
Overview
What does DERMATHEEK do?
DERMATHEEK is a Private limited company incorporated in 1990. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Ranst. It employs on average 28,1 ETP workers (FTE).
2520 Ranst · FlandreSee on map
Joint committees (1)
- 313
Trend over 18 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||
| Gross margin | 2,3 M € | +12.9% | 2,1 M € | +22.2% | 1,7 M € | +4.7% | 1,6 M € | +14.2% | 1,4 M € | +35.7% | 1 M € | +9.7% | 944,1 k € | +34.4% | 702,4 k € | +24.4% | 564,8 k € | -2.9% | 581,4 k € | +48.2% | 392,3 k € | -9.6% | 433,7 k € | +12.5% | 385,6 k € | -30.9% | 557,9 k € | -8.7% | 611,1 k € | +34.8% | 453,4 k € | -23.1% | 590 k € | +87.4% | 314,9 k € |
| EBITDA | 711,6 k € | +2.3% | 695,5 k € | +47.7% | 471 k € | -25.5% | 632,3 k € | +60.6% | 393,6 k € | +78.5% | 220,6 k € | -0.5% | 221,7 k € | +8.8% | 203,7 k € | +32.2% | 154,1 k € | -43.2% | 271,3 k € | +67.8% | 161,7 k € | -31.9% | 237,4 k € | +26.6% | 187,4 k € | -47.2% | 355,2 k € | -16.8% | 426,8 k € | +35.9% | 314 k € | -27.0% | 430,5 k € | +155% | 168,8 k € |
| Operating result | 422,5 k € | -9.4% | 466,4 k € | +57.9% | 295,3 k € | -39.4% | 487,2 k € | +101% | 241,9 k € | +321% | 57,4 k € | -5.3% | 60,7 k € | -54.9% | 134,6 k € | +6.8% | 126 k € | -46.5% | 235,7 k € | +76.0% | 133,9 k € | -36.2% | 209,8 k € | +34.0% | 156,6 k € | -51.8% | 324,8 k € | -15.8% | 385,8 k € | +53.8% | 250,9 k € | -29.5% | 356 k € | +268% | 96,7 k € |
| Net result | 243,9 k € | -20.6% | 307,1 k € | +68.8% | 182 k € | -51.9% | 378 k € | +173% | 138,3 k € | +1192% | 10,7 k € | -15.4% | 12,7 k € | -80.7% | 65,5 k € | -17.1% | 79 k € | -47.5% | 150,4 k € | +75.0% | 86 k € | -35.6% | 133,5 k € | +26.7% | 105,4 k € | -51.3% | 216,3 k € | -12.2% | 246,3 k € | +152% | 97,7 k € | -64.1% | 272,2 k € | +643% | 36,6 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||
| Equity | 804,2 k € | +14.2% | 704 k € | +16.6% | 603,6 k € | +27.1% | 474,9 k € | +26.9% | 374,2 k € | +53.9% | 243,1 k € | +4.6% | 232,4 k € | +5.8% | 219,8 k € | +0.2% | 219,2 k € | +15.3% | 190,2 k € | +36.1% | 139,8 k € | +34.7% | 103,8 k € | +47.7% | 70,3 k € | -91.9% | 864,9 k € | -30.7% | 1,2 M € | +24.6% | 1 M € | +10.8% | 904,6 k € | +41.9% | 637,5 k € |
| Total assets | 5,4 M € | +7.8% | 5 M € | +37.2% | 3,7 M € | +4.8% | 3,5 M € | +20.0% | 2,9 M € | +6.3% | 2,8 M € | +0.8% | 2,7 M € | +3.2% | 2,6 M € | +144% | 1,1 M € | +18.3% | 913,9 k € | +27.3% | 718,1 k € | -2.3% | 734,9 k € | -45.0% | 1,3 M € | -31.3% | 1,9 M € | -0.7% | 2 M € | +4.4% | 1,9 M € | +2.2% | 1,8 M € | +11.3% | 1,6 M € |
| Cash | 228,6 k € | -36.4% | 359,4 k € | +6.7% | 336,9 k € | +192% | 115,3 k € | -42.8% | 201,7 k € | +13.8% | 177,2 k € | +43.8% | 123,2 k € | -71.8% | 437,1 k € | +176% | 158,6 k € | +108% | 76,2 k € | +9.4% | 69,7 k € | -42.1% | 120,4 k € | +22.5% | 98,3 k € | -13.7% | 113,8 k € | -5.5% | 120,4 k € | +382% | 25 k € | +43.1% | 17,4 k € | -86.5% | 128,9 k € |
| Debts | 4,6 M € | +6.8% | 4,3 M € | +40.4% | 3,1 M € | +1.4% | 3 M € | +19.2% | 2,5 M € | +1.5% | 2,5 M € | +0.4% | 2,5 M € | +3.0% | 2,4 M € | +181% | 859,6 k € | +19.1% | 721,5 k € | +25.2% | 576,3 k € | -8.4% | 629,2 k € | -50.2% | 1,3 M € | +17.2% | 1,1 M € | +52.1% | 708,6 k € | -18.7% | 871,8 k € | -2.2% | 891,7 k € | -11.7% | 1 M € |
| Other | |||||||||||||||||||||||||||||||||||
| Workforce | 28,1 ETP | +16.1% | 24,2 ETP | +11.0% | 21,8 ETP | +10.7% | 19,7 ETP | -3.0% | 20,3 ETP | +16.0% | 17,5 ETP | +11.5% | 15,7 ETP | +12.1% | 14,0 ETP | +33.3% | 10,5 ETP | +18.0% | 8,9 ETP | +34.8% | 6,6 ETP | +61.0% | 4,1 ETP | +2.5% | 4,0 ETP | -7.0% | 4,3 ETP | +4.9% | 4,1 ETP | +20.6% | 3,4 ETP | +3.0% | 3,3 ETP | 0.0% | 3,3 ETP |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2024 · 4 active · 10 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
APOTHEEK TANGHE● Active | 0870.737.425 |
JM CAPITAL● Active | 0664.825.429 |
P.J.A. BEHEER● Active | 0861.392.662 |
PJA Retail● Active | 0730.880.746 |
Financials
Full financial information
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 14/08/2025 | 13/08/2024 | 31/08/2023 | 26/08/2022 | 11/10/2021 | 17/07/2020 |
| General meeting | 02/06/2025 | 01/06/2024 | 21/04/2023 | 27/05/2022 | 29/09/2021 | 07/07/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
20 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2024 | 02/06/2025 | 14/08/2025 | Dutch | |
| Abridged model | 31/12/2023 | 01/06/2024 | 13/08/2024 | Dutch | |
| Abridged model | 31/12/2022 | 21/04/2023 | 31/08/2023 | Dutch | |
| Abridged model | 31/12/2021 | 27/05/2022 | 26/08/2022 | Dutch | |
| Abridged modelCorrection | 31/12/2020 | 29/09/2021 | 11/10/2021 | Dutch | |
| Abridged model | 31/12/2020 | 07/05/2021 | 05/06/2021 | Dutch | |
| Abridged model | 31/12/2019 | 07/07/2020 | 17/07/2020 | Dutch | |
| Abridged model | 31/12/2018 | 30/06/2019 | 11/07/2019 | Dutch | |
| Abridged model | 31/12/2017 | 30/06/2018 | 30/07/2018 | Dutch | |
| Abridged model | 31/12/2016 | 21/04/2017 | 08/06/2017 | Dutch | |
| Abridged model | 31/12/2015 | 15/04/2016 | 27/06/2016 | Dutch | |
| Abridged model | 31/12/2014 | 17/04/2015 | 03/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 18/04/2014 | 06/06/2014 | Dutch | |
| Abridged model | 31/12/2012 | 19/04/2013 | 24/05/2013 | Dutch | |
| Abridged model | 31/12/2011 | 20/04/2012 | 25/06/2012 | Dutch | |
| Abridged model | 31/12/2010 | 15/04/2011 | 09/06/2011 | Dutch | |
| Abridged model | 31/12/2009 | 16/04/2010 | 22/04/2010 | Dutch | |
| Abridged model | 31/12/2008 | 17/04/2009 | 29/05/2009 | Dutch | |
| Abridged model | 31/12/2007 | 18/04/2008 | 05/05/2008 | Dutch | |
| Abridged model | 31/12/2006 | 20/04/2007 | 14/05/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2024 · 4 active · 10 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Mandates12/01/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
- Mandates14/02/2023ONTSLAGEN - BENOEMINGEN
- Mandates28/10/2021ONTSLAGEN - BENOEMINGEN
- Registered office19/07/2019MAATSCHAPPELIJKE ZETEL
- Mandates02/03/2018ONTSLAGEN - BENOEMINGEN
- Restructuring24/01/2018RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ... - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Restructuring31/10/2017RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Mandates02/03/2006ONTSLAGEN - BENOEMINGEN
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024243,9 k €↓
- 2023Annual accounts 2023307,1 k €↑
- 2022Annual accounts 2022182 k €↓
- 2021Annual accounts 2021378 k €↑
- 2020Annual accounts 2020138,3 k €↑
- 2019Annual accounts 201910,7 k €↓
- 2018Annual accounts 201812,7 k €↓
- 2017Annual accounts 201765,5 k €↓
- 2016Annual accounts 201679 k €↓
- 2015Annual accounts 2015150,4 k €↑
- 2014Annual accounts 201486 k €↓
- 2013Annual accounts 2013133,5 k €↑
- 2012Annual accounts 2012105,4 k €↓
- 2011Annual accounts 2011216,3 k €↓
- 2010Annual accounts 2010246,3 k €↑
- 2009Annual accounts 200997,7 k €↓
- 2008Annual accounts 2008272,2 k €↑
- 2007Annual accounts 200736,6 k €
- 26/07/1990IncorporationPrivate limited company